摘要
目的观察两种方法治疗幽门螺杆菌性溃疡患者的临床疗效。方法本样本回顾分析2007年1月~2009年12月阔住院病人Hp阳性消化性溃疡患者112例临床治疗资料。结果治疗组溃疡愈合率92.86%,对照组溃疡愈合率78.57%,两组比较差异具有显著性(P〈0.05),治疗组Hp根除率为80.36%,而对照组为55.36%,两组比较差异具有显著性(P〈0.05)。结论奥美拉唑根徐Hp消化性溃疡的作用优越于雷尼替丁,值得临床进一步推广应用。
Objective Observes two method treatment pylorus spiral bacillary ulcer patient's clinical curative effect. Methods This sample review analyzes in January, 2009-2009 during year December in-patient Hp masculine gender digestive ulcer patient 112 example clinical care material. Results The treatment group ulcer recovery rate 92.86%, the control group ulcer recovery rate 78.57%, two group of comparison differences have the significance (P〈O.OS),Treatment group Hp eradication rate is 80.36%, but the control group is 55.36%, two group of comparison differences have the significance (P〈0.05). Conclusions The Austria US pulls zuo eradicates the Hp digestive ulcer's function superiorly in Leinitiding, is worth clinical further promoting the application.
作者
钟家民
ZHONG Jia-min (Zigong city Along the Yellow People's Hospital SiehuanProvinee,Zigong 643030, China)
出处
《医学信息》
2011年第5期1246-1247,共2页
Journal of Medical Information
关键词
幽门螺杆菌
溃疡
奥美拉唑
雷尼替丁
Pylorus spiral bacillus
Ulcer
, The Austria US pulls zuo
Leinitiding